Importantly, reduced GLS activity in tumor cells drove an enriched progenitor exhausted T cell phenotype, which can be reinvigorated by ICB.[55] Our data suggest that enhanced antigen presentation by tumor cells can lead to these improved T cell responses. This evidence concerns the gene GLS and neoplasm.